| Mar 12, 2025 |
Mar 14, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
20.0
|
-362,966
|
-9.50%
|
✗
|
$798K |
| Mar 7, 2025 |
Mar 11, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
22.5
|
-47,477
|
-1.23%
|
✗
|
$96.2K |
| Mar 4, 2025 |
Mar 6, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
36.3
|
-21,531
|
-0.55%
|
✗
|
$44.6K |
| Jul 18, 2023 |
Jul 20, 2023 |
Sagimet Biosciences Inc.
|
10% Owner |
Buy |
67.5
|
+29,338
|
0.38%
|
✗
|
$469.4K |
| Apr 5, 2022 |
Apr 7, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-694,551
|
-21.01%
|
✗
|
$751.3K |
| Jan 21, 2022 |
Jan 25, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
22.5
|
-134,558
|
-3.91%
|
✗
|
$202.2K |
| Jan 18, 2022 |
Jan 20, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-26,555
|
-0.77%
|
✗
|
$48.7K |
| Jan 12, 2022 |
Jan 14, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-21,550
|
-0.62%
|
✗
|
$41.8K |
| Jan 7, 2022 |
Jan 11, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-18,760
|
-0.53%
|
✗
|
$38.7K |
| Jan 4, 2022 |
Jan 6, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
32.5
|
-31,916
|
-0.90%
|
✗
|
$72.2K |
| Dec 30, 2021 |
Jan 3, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-116,476
|
-3.19%
|
✗
|
$266.9K |
| Dec 27, 2021 |
Dec 29, 2021 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
22.5
|
-67,427
|
-1.81%
|
✗
|
$159.5K |
| Dec 9, 2021 |
Dec 27, 2021 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-291,152
|
-7.25%
|
✗
|
$688.5K |
| Aug 17, 2020 |
Aug 18, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
16.3
|
-245,904
|
-8.17%
|
✗
|
$9.8M |
| Aug 17, 2020 |
Aug 18, 2020 |
Sprout Social, Inc.
|
10% Owner |
Sell |
15.0
|
-3,441,846
|
-38.14%
|
✗
|
$94.7M |
| Aug 11, 2020 |
Aug 13, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
17.5
|
-64,604
|
-2.10%
|
✗
|
$2.5M |
| Aug 7, 2020 |
Aug 10, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
20.0
|
-20,748,632
|
-87.10%
|
✗
|
$568.2K |
| May 19, 2020 |
May 21, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
17.5
|
-5,264,785
|
-56.46%
|
✗
|
$2.2M |
| Aug 28, 2019 |
Apr 13, 2020 |
Mersana Therapeutics, Inc.
|
10% Owner |
Sell |
52.5
|
-1,211
|
-0.01%
|
✗
|
$3.5K |
| Mar 16, 2020 |
Mar 16, 2020 |
Enliven Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+475,000
|
13.42%
|
✗
|
$7.6M |
| Mar 6, 2020 |
Mar 10, 2020 |
CHAMPIONS ONCOLOGY, INC.
|
10% Owner |
Sell |
17.5
|
-708,155
|
-29.24%
|
✗
|
$5M |
| Nov 12, 2019 |
Nov 12, 2019 |
Galera Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+416,666
|
10.57%
|
✗
|
$5M |
| Mar 5, 2019 |
Mar 6, 2019 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+3,750,000
|
46.07%
|
✗
|
$15M |
| Sep 7, 2018 |
Sep 10, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
93.8
|
+3,000,000
|
3.75%
|
✗
|
$5M |
| Mar 26, 2018 |
Mar 28, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
97.5
|
+6,571,164
|
8.95%
|
✗
|
$12.6M |
| Mar 21, 2018 |
Mar 23, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
87.5
|
+1,268,508
|
1.76%
|
✗
|
$2.4M |
| Nov 27, 2017 |
Nov 27, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-569,620
|
-100.00%
|
✗
|
$11.1M |
| Nov 20, 2017 |
Nov 21, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-2,820,516
|
-100.00%
|
✗
|
$55M |
| Oct 10, 2017 |
Oct 10, 2017 |
RHYTHM PHARMACEUTICALS, INC.
|
10% Owner |
Buy |
100.0
|
+550,000
|
12.61%
|
✗
|
$9.4M |
| Jul 3, 2017 |
Jul 6, 2017 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
14.01%
|
✗
|
$15M |
| Mar 27, 2017 |
Mar 28, 2017 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+12,870,000
|
21.71%
|
✗
|
$9M |
| Jul 18, 2016 |
Jul 20, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
96.3
|
+763,650
|
9.56%
|
✗
|
$6.7M |
| Jan 13, 2016 |
Jan 14, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
96.3
|
+500,000
|
6.68%
|
✗
|
$5M |
| Oct 5, 2015 |
Oct 6, 2015 |
SYNLOGIC, INC.
|
10% Owner |
Buy |
100.0
|
+1,146,308
|
21.08%
|
✗
|
$6M |
| Jun 5, 2015 |
Jun 9, 2015 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+1,869,159
|
33.26%
|
✗
|
$20M |
| Aug 27, 2014 |
Aug 29, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-266,700
|
-5.41%
|
✗
|
$2.1M |
| Aug 8, 2014 |
Aug 12, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-710,540
|
-12.61%
|
✗
|
$4.7M |
| Jan 15, 2014 |
Jan 15, 2014 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
100.0
|
+512,500
|
14.31%
|
✗
|
$4.1M |
| Jun 30, 2010 |
Jul 2, 2010 |
Viracta Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+23,824,451
|
100.00%
|
✗
|
$6.6M |